Sodium-glucose co-transporter-2 inhibition vs. dipeptidyl peptidase-4 inhibition in diabetic kidney transplant recipients: Single center experience

被引：0
|
作者：
Gheith, Osama [1 ]
AlOtaibi, Torki M. [1 ]
Mostafa, Ahmed Y. [1 ]
Shaker, Mohamed [1 ]
Khalid, Mahmoud [1 ]
Emam, Mohamed [1 ]
Mostafa, Mohammed [1 ]
Nagib, Ayman Maher [1 ]
Alserwy, Nabil [1 ]
Othman, Nashwa [1 ]
Dahab, Mohamed [1 ]
Nair, Prasad [1 ]
Denewar, Ahmed [1 ]
机构：
[1] Hamad Alessa OTC, Kuwait, Kuwait
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
441.3
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose co-transporter-2 inhibition vs. dipeptidyl peptidase-4 inhibition in diabetic kidney transplant recipients: Single center experience
    Gheith, Osama
    Alotaibi, Torki M.
    Mostafa, Ahmed Y.
    Shaker, Mohamed
    Khalid, Mahmoud
    Emam, Mohamed
    Mostafa, Mohammed
    Nagib, Ayman Maher
    Alserwy, Nabil
    Othman, Nashwa
    Dahab, Mohamed
    Nair, Prasad
    Denewar, Ahmed
    TRANSPLANTATION, 2024, 108 (9S)
  • [2] Study the Effect of Sodium-Glucose Cotransporter-2 Inhibition Versus Dipeptidyl Peptidase-4 Inhibition in Diabetic Kidney Transplant Recipients
    Aotaibi, Torki
    Gheith, Osama
    Elsayed, Zakaria
    Yahya, Ahmed
    Shaker, Mohamed
    Khalid, Mahmoud
    Emam, Mohamed
    Mostafa, Mohamed
    Abdul-Hameed, Mohamed
    Maher, Ayman
    Denewar, Ahmed
    Dahab, Mohamed
    Elserwy, Nabil
    Othman, Nashwa
    Nair, Prasad
    TRANSPLANTATION, 2022, 106 (09) : S556 - S556
  • [3] Superior benefits of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors for diabetic kidney disease: A cohort study
    Chen, Hsiao-Ling
    Wang, I-Ting
    Tsai, Yi-Wen
    Lee, Yu-Hsuan
    Chen, Chen-Huan
    Chiang, Chern-En
    Cheng, Hao-Min
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 174 - 183
  • [4] Single Center Experience With Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Kidney Transplant Recipients With Diabetes
    Angjeli, Albi
    Montada-Atin, Tess
    Nisenbaum, Rosane
    Dacouris, Niki
    Nash, Michelle
    Prasad, G.
    Zaltzman, Jeffrey
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2024, 11
  • [5] Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes
    Sharma, M. D.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 616 - 621
  • [6] Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors
    Fadini, Gian Paolo
    Bonora, Benedetta Maria
    Mayur, Sarangdhar
    Rigato, Mauro
    Avogaro, Angelo
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 740 - 744
  • [7] Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences
    Singh, Awadhesh Kumar
    Singh, Ritu
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 229 - 240
  • [8] Combined effect of sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors for diabetic kidney disease
    Araki, Shin-ichi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (01) : 22 - 24
  • [9] Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease
    Rhee, Jinnie J.
    Han, Jialin
    Montez-Rath, Maria E.
    Kim, Sun H.
    Cullen, Mark R.
    Stafford, Randall S.
    Winkelmayer, Wolfgang C.
    Chertow, Glenn M.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 928 - 937
  • [10] Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus
    Buckley, Sophieanne
    Subramaniam, Yuvanaa
    Mallik, Ritwika
    Mukuba, Dorcas
    Casabar, Mahalia
    Ali, Omer
    Byrne, Connor
    Chowdhury, Tahseen A.
    DIABETIC MEDICINE, 2024, 41 (08)
12345